News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Joanna Glasner, Reuters | 09.02.2014
Synthetic biology, which uses engineered gene sequences to create new biological systems and devices, used to be a subject for...
By The Times News, The Times News | 09.01.2014

It’s hard to blame Elnora Mills for not feeling terribly grateful. Decades after being forcibly sterilized under the state eugenics...

By Press Association, Press Association | 09.01.2014

Britain risks being considered a "rogue state" if it pushes ahead with developing "genetically modified people", MPs were told.

Conservative...

By Richard Van Noorden, Nature News | 09.01.2014

Scientists who work on genomics and are funded by the US National Institutes of Health (NIH) must post their data...

By Russia Today, Russia Today | 09.01.2014

Upon meeting a 28,000-year-old mammoth mummy in a museum in the Russian Far East, Russian President Vladimir Putin wondered if...

By Carl Zimmer, National Geographic | 08.31.2014
People coming to the zoo to see the last passenger pigeon were disappointed by the bird, which barely budged off...
By Ian Duncan, The Baltimore Sun | 08.30.2014
As the state's highest court upheld this week a Harford County rape conviction based on DNA collected from the arm...
By Stephanie M. Lee, San Francisco Chronicle | 08.29.2014

Almost three years after a Bay Area company shut down the world's first clinical trial of a therapy using embryonic...